Alain brings 32 years of experience in the Life Sciences sector. He started his career in the mid 1980’s as head of the emergency room in a large teaching hospital in France and practiced as a General Practitioner for four years.

Alain then spent 12 years in biotechnology drug development and regulatory strategy as Vice President of Quintiles (IQVIA) Biotech in Europe. Later on he became a Life Sciences entrepreneur, Associate Partner at Truffle Capital, CEO of Neovacs and TcLand (TcLand Expression and Ose-immunotherapeutics). He has successfully founded 5 French biotechnology companies. He has been involved in precision medicine through his work as Founder and Chairman of EPEMED, the European Personalized Medicine Association. Alain joined Advent Life Sciences in 2012 and founded AdBio Partners (formerly Advent France Biotechnology) in 2016 managing early stage Life Sciences seed funds.

Back to Team